The Washington Post ran an illuminating article back in February 2006 titled “Divided Loyalties?” about nonprofit health advocacy groups that appear to be on the consumer’s side, but that some observers say actually put their corporate donors’ interests ahead of their constituencies’ welfare.
According to the article, corporate donations to these organizations seem to dictate the organizations’ hesitancy to weigh in on controversial subjects such as drug safety. A chart at the end of the article showed which major drug companies gave to major organizations such as the American Heart Association, the American Diabetes Association, the National Osteoporosis Foundation, the Arthritis Foundation, and the Lung Cancer Alliance. The donations were huge!
Next post will survey the scene since 2006.